Biome Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-06-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 31.55%
(FY 2023)
- Profit 52.44%
(FY 2023)
- Ebitda 48.02%
(FY 2023)
- Net Worth 88.53%
(FY 2023)
- Total Assets 91.87%
(FY 2023)
About Biome Life Sciences India
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Viney Singh, Mukesh Chauhan, Shantanu Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100DL2019PTC356473
- Company No.
356473
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 2019
- Date of AGM
27 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biome Life Sciences India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sania Arora  | Managing Director | 22-Oct-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Viney Singh | Director | 01-Aug-2020 | Current |
| Mukesh Chauhan | Director | 01-Aug-2020 | Current |
| Shantanu Jain | Director | 22-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Biome Life Sciences India.
Biome Life Sciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.55% increase. The company also saw a substantial improvement in profitability, with a 52.44% increase in profit. The company's net worth Soared by an impressive increase of 88.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biome Life Sciences India?
In 2023, Biome Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biome Life Sciences India?
Biome Life Sciences India has a workforce of 15 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biome Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biome Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
